We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Telstar Promotes Latest Generation of Freeze Dryers in Dubai

By LabMedica International staff writers
Posted on 31 Jan 2019
Print article
Image: The LyoQuest bench-top laboratory freeze dryer (Photo courtesy of Telstar).
Image: The LyoQuest bench-top laboratory freeze dryer (Photo courtesy of Telstar).
Telstar (Shanghai, China) displayed the latest generation of compact laboratory freeze dryers at MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019. The event saw more than 19,610 unique visitors and 678+ exhibitors sharing the most recent technology available in the IVD, and medical laboratory market.

Among its products exhibited at MedLab Middle East 2019 was the Telstar LyoQuest, a bench-top laboratory freeze dryer that combines this breadth of functionality into a single unit so that users can perform complete cycles on a range of sample containers (vials, trays, ampoules, and flasks) using the same piece of equipment. LyoQuest also enables users to create recipes comprising time, temperature and vacuum control via its integrated PLC control system. Its innovative design results in an extremely compact unit with large condensation capacity up to eight liters and enables many product formats to be pre-frozen by the device, without the need for an additional freezer. The LyoQuest’s ice condenser includes an automatic defrosting function for quick and easy de-icing.

The company also promoted the Telstar Bio II Advance Plus compact range of microbiological safety cabinets (MSC) that are intended for the laminar flow manipulation of microorganisms with biological risk levels 2 and 3. Their innovative cabinet design offers smaller body than the market average while maintaining standard workspace. With dimensions of 759 mm in width and 1260 mm in height, the Bio II Advance Plus provides a working volume of 340 dm3. Equipped to achieve maximum efficiency, this new range of MSC integrates energy saving EC fans and LED illumination that ensures optimum protection levels as well as low energy consumption. Bio II Advance Plus is designed in compliance with the European standards EN 12469 and certified by TÜV-Nord.

Telstar also displayed Boreas, a new -86º ultra-low-temperature freezer designed to increase average performance by 20% and featuring an innovative mechanical design that enhances robustness, efficiency and ergonomics as well as ensures the integrity of the cold preservation process. Equipped with vacuum panels VIP, the freezer guarantees the highest level of thermal insulation and a temperature of -80ºC under an ambient up to +28ºC. Unlike standard freezers designed with panels based on polyurethane foam, a thinner inner insulation provides Boreas with an enlarged storage capacity of up to 30%. Boreas uses high purity natural refrigerant gases to contribute to environment preservation and does not damage the ozone layer. The ecological ultra-low-freezers line has been developed using Telstar’s in-house cold storage technology.

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.